The Journey to JAKs: First-in-Class Drugs to Treat Alopecia Areata

Time: 11:45 am
day: Day Two

Details:

  • Overviewing the science that provided the rationale for JAK inhibitors in Alopecia Areata
  • Discussing biomarkers of treatment response and patient selection
  • Looking ahead to the next-generation JAK inhibitors in Alopecia Areata

Speakers: